{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:34:04Z","timestamp":1769556844686,"version":"3.49.0"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["IHS-2019C1-16167"],"award-info":[{"award-number":["IHS-2019C1-16167"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH\/NCATS Colorado CTSA","award":["UL1 TR002535"],"award-info":[{"award-number":["UL1 TR002535"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Opioid use disorder (OUD) represents a public health crisis in the United States. Medication for opioid use disorder (MOUD) with buprenorphine in primary care is a proven OUD treatment strategy. MOUD induction is when patients begin withdrawal and receive the first doses of buprenorphine. Differences between induction methods might influence short-term stabilization, long-term maintenance, and quality of life. This paper describes the protocol for a study designed to: (1) compare short-term stabilization and long-term maintenance treatment engagement in MOUD in patients receiving office, home, or telehealth induction and (2) identify clinically-relevant practice and patient characteristics associated with successful long-term treatment. The study design is a randomized, parallel group, pragmatic comparative effectiveness trial of three care models of MOUD induction in 100 primary care practices in the United States. Eligible patients are at least 16 years old, have been identified by their clinician as having opioid dependence and would benefit from MOUD. Patients will be randomized to one of three induction comparators: office, home, or telehealth induction. Primary outcomes are buprenorphine medication-taking and illicit opioid use at 30, 90, and 270 days post-induction. Secondary outcomes include quality of life and potential mediators of treatment maintenance (intentions, planning, automaticity). Potential moderators include social determinants of health, substance use history and appeal, and executive function. An intent to treat analysis will assess effects of the interventions on long-term treatment, using general\/generalized linear mixed models, adjusted for covariates, for the outcomes analysis. Analysis includes practice- and patient-level random effects for hierarchical\/longitudinal data. No large-scale, randomized comparative effectiveness research has compared home induction to office or telehealth MOUD induction on long-term outcomes for patients with OUD seen in primary care settings. The results of this study will offer primary care providers evidence and guidance in selecting the most beneficial induction method(s) for specific patients.<\/jats:p>","DOI":"10.1371\/journal.pone.0290388","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T17:24:06Z","timestamp":1694193846000},"page":"e0290388","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["A randomized, parallel group, pragmatic comparative-effectiveness trial comparing medication-assisted treatment induction methods in primary care practices: The HOMER study protocol"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7392-0113","authenticated-orcid":true,"given":"Douglas H.","family":"Fernald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald E.","family":"Nease","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Westfall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bethany M.","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Miriam","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Sofie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6589-4557","authenticated-orcid":true,"given":"Cory","family":"Lutgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer K.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Heeren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maret","family":"Felzien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Zittleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,9,8]]},"reference":[{"issue":"5","key":"pone.0290388.ref001","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jama.2017.10046","article-title":"Both Urgency and Balance Needed in Addressing Opioid Epidemic: A Report From the National Academies of Sciences, Engineering, and Medicine","volume":"318","author":"RJ Bonnie","year":"2017","journal-title":"JAMA: the journal of the American Medical Association"},{"key":"pone.0290388.ref002","unstructured":"HHS Secretary Becerra Announces New Overdose Prevention Strategy [Internet]. Washington, DC: U.S. Department of Health & Human Services; 2021; October 27, 2021 [cited March 30, 2023]. https:\/\/public3.pagefreezer.com\/browse\/HHS.gov\/30-12-2021T15:27\/https:\/\/www.hhs.gov\/about\/news\/2021\/10\/27\/hhs-secretary-becerra-announces-new-overdose-prevention-strategy.html"},{"key":"pone.0290388.ref003","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction","volume":"36","author":"A Kolodny","year":"2015","journal-title":"Annual review of public health"},{"issue":"4","key":"pone.0290388.ref004","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1370\/afm.2111","article-title":"Now is the Time to Address Substance Use Disorders in Primary Care","volume":"15","author":"R Saitz","year":"2017","journal-title":"Ann Fam Med"},{"key":"pone.0290388.ref005","unstructured":"Drug Overdose Deaths in the U.S. Top 100,000 Annually [Internet]. Centers for Disease Control and Prevention,; 2021; November 17, 2021 [cited May 9, 2022]. https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2021\/20211117.htm"},{"key":"pone.0290388.ref006","unstructured":"Center for Substance Abuse Treatment. SAMHSA\/CSAT Treatment Improvement Protocols. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. SAMHSA\/CSAT Treatment Improvement Protocols. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2004."},{"issue":"18","key":"pone.0290388.ref007","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","volume":"343","author":"RE Johnson","year":"2000","journal-title":"The New England journal of medicine"},{"issue":"10","key":"pone.0290388.ref008","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"349","author":"PJ Fudala","year":"2003","journal-title":"The New England journal of medicine"},{"issue":"1","key":"pone.0290388.ref009","first-page":"3019","article-title":"Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians","volume":"15","author":"JR DeFlavio","year":"2015","journal-title":"Rural Remote Health"},{"issue":"4","key":"pone.0290388.ref010","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1370\/afm.2099","article-title":"Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder","volume":"15","author":"CHA Andrilla","year":"2017","journal-title":"Ann Fam Med"},{"issue":"5","key":"pone.0290388.ref011","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1521\/jscp.23.5.675.50744","article-title":"Motivation, autonomy support, and entity beliefs: Their role in methadone maintenance treatment","volume":"23","author":"A Zeldman","year":"2004","journal-title":"Journal of Social and Clinical Psychology"},{"issue":"1","key":"pone.0290388.ref012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/aphw.12017","article-title":"Implementation intention and action planning interventions in health contexts: state of the research and proposals for the way forward","volume":"6","author":"MS Hagger","year":"2014","journal-title":"Appl Psychol Health Well Being"},{"issue":"4","key":"pone.0290388.ref013","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/ejsp.258","article-title":"Action planning and coping planning for long\u2010term lifestyle change: theory and assessment","volume":"35","author":"FF Sniehotta","year":"2005","journal-title":"European Journal of Social Psychology"},{"key":"pone.0290388.ref014","article-title":"Adherence to advice and treatment","volume":"9","author":"R Horne","year":"2010","journal-title":"Health psychology"},{"issue":"9","key":"pone.0290388.ref015","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s11606-008-0686-x","article-title":"Office-Based Management of Opioid Dependence with Buprenorphine: Clinical Practices and Barriers","volume":"23","author":"AY Walley","year":"2008","journal-title":"Journal of General Internal Medicine"},{"key":"pone.0290388.ref016","unstructured":"Center for Substance Abuse Treatment. Medications for Opioid Use Disorders. Treatment Improvement Protocol (TIP) Series 63. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2021 Contract No.: PEP21-02-01-002."},{"issue":"2","key":"pone.0290388.ref017","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1348\/014466607X230876","article-title":"Habit vs. intention in the prediction of future behaviour: The role of frequency, context stability and mental accessibility of past behaviour","volume":"47","author":"UN Danner","year":"2008","journal-title":"British Journal of Social Psychology"},{"key":"pone.0290388.ref018","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/spc3.12265","volume":"10","author":"P Sheeran","year":"2016","journal-title":"The Intention-behavior gap. social and personality psychology compass"},{"issue":"11","key":"pone.0290388.ref019","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1111\/j.1360-0443.2010.03028.x","article-title":"Using theories of behaviour change to inform interventions for addictive behaviours","volume":"105","author":"TL Webb","year":"2010","journal-title":"Addiction (Abingdon, England)"},{"issue":"10","key":"pone.0290388.ref020","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.addbeh.2011.05.012","article-title":"The role of executive function in bridging the intention-behaviour gap for binge-drinking in university students","volume":"36","author":"B Mullan","year":"2011","journal-title":"Addictive behaviors"},{"key":"pone.0290388.ref021","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neubiorev.2016.05.018","article-title":"Cognitive training for substance use disorders: Neuroscientific mechanisms. Neuroscience &","volume":"68","author":"A. Verdejo-Garcia","year":"2016","journal-title":"Biobehavioral Reviews"},{"key":"pone.0290388.ref022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2016.02.010","article-title":"Assessment of executive function in patients with substance use disorder: A comparison of inventory-and performance-based assessment","volume":"66","author":"E Hagen","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"6","key":"pone.0290388.ref023","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40263-019-00637-z","article-title":"Buprenorphine Treatment for Opioid Use Disorder: An Overview","volume":"33","author":"M Shulman","year":"2019","journal-title":"CNS drugs"},{"key":"pone.0290388.ref024","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/9781108677318.006","volume-title":"The handbook of behavior change. Cambridge handbooks in psychology","author":"L Keller","year":"2020"},{"issue":"4","key":"pone.0290388.ref025","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/1745691612447309","article-title":"Self-Determination Theory Applied to Health Contexts: A Meta-Analysis","volume":"7","author":"JY Ng","year":"2012","journal-title":"Perspect Psychol Sci"},{"issue":"1","key":"pone.0290388.ref026","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1370\/afm.1591","article-title":"Practice facilitation to improve diabetes care in primary care: a report from the EPIC randomized clinical trial","volume":"12","author":"WP Dickinson","year":"2014","journal-title":"Ann Fam Med"},{"issue":"1","key":"pone.0290388.ref027","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1370\/afm.2757","article-title":"Increasing Capacity for Treatment of Opioid Use Disorder in Rural Primary Care Practices","volume":"20","author":"L Zittleman","year":"2022","journal-title":"Ann Fam Med"},{"issue":"4","key":"pone.0290388.ref028","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jsat.2010.12.002","article-title":"A comparison of buprenorphine induction strategies: patient-centered home-based inductions versus standard-of-care office-based inductions","volume":"40","author":"CO Cunningham","year":"2011","journal-title":"J Subst Abuse Treat"},{"issue":"5","key":"pone.0290388.ref029","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/ADM.0000000000000059","article-title":"Unobserved \"home\" induction onto buprenorphine","volume":"8","author":"JD Lee","year":"2014","journal-title":"J Addict Med"},{"key":"pone.0290388.ref030","unstructured":"Department of Health and Human Services. Opioid Treatment Program (OTP) Guidance. In: Substance Abuse and Mental Health Services Administration, editor. Rockville, MD2020."},{"key":"pone.0290388.ref031","unstructured":"American Society of Addiction Medicine. The ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. The International Guidelines Center; 2015."},{"issue":"2","key":"pone.0290388.ref032","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The Clinical Opiate Withdrawal Scale (COWS)","volume":"35","author":"DR Wesson","year":"2003","journal-title":"J Psychoactive Drugs"},{"issue":"3","key":"pone.0290388.ref033","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/00952998709001515","article-title":"Two new rating scales for opiate withdrawal","volume":"13","author":"L Handelsman","year":"1987","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"1","key":"pone.0290388.ref034","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","article-title":"Retention in medication-assisted treatment for opiate dependence: A systematic review","volume":"35","author":"C Timko","year":"2016","journal-title":"J Addict Dis"},{"key":"pone.0290388.ref035","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.drugalcdep.2015.09.008","article-title":"Item banks for substance use from the Patient-Reported Outcomes Measurement Information System (PROMIS((R))): Severity of use and positive appeal of use","volume":"156","author":"PA Pilkonis","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"pone.0290388.ref036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2016.02.010","article-title":"Assessment of Executive Function in Patients With Substance Use Disorder: A Comparison of Inventory- and Performance-Based Assessment","volume":"66","author":"E Hagen","year":"2016","journal-title":"J Subst Abuse Treat"},{"key":"pone.0290388.ref037","doi-asserted-by":"crossref","unstructured":"Billioux A, Verlander K, Anthony S, Alley D. Standardized Screening for Health-Related Social Needs in Clinical Settings: The Accountable Health Communities Screening Tool. NAM Perspectives. Washington, DC: Discussion Paper, National Academy of Medicine; 2017.","DOI":"10.31478\/201705b"},{"issue":"1","key":"pone.0290388.ref038","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1017\/S1742058X11000087","article-title":"RACIAL DISPARITIES IN HEALTH: How Much Does Stress Really Matter?","volume":"8","author":"MJ Sternthal","year":"2011","journal-title":"Du Bois Rev"},{"issue":"3","key":"pone.0290388.ref039","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1037\/0022-3514.39.3.472","article-title":"The revised UCLA Loneliness Scale: concurrent and discriminant validity evidence","volume":"39","author":"D Russell","year":"1980","journal-title":"J Pers Soc Psychol"},{"issue":"10","key":"pone.0290388.ref040","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.2337\/diacare.21.10.1644","article-title":"Supporting autonomy to motivate patients with diabetes for glucose control","volume":"21","author":"GC Williams","year":"1998","journal-title":"Diabetes care"},{"issue":"1","key":"pone.0290388.ref041","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1037\/0022-3514.70.1.115","article-title":"Motivational predictors of weight loss and weight-loss maintenance","volume":"70","author":"GC Williams","year":"1996","journal-title":"J Pers Soc Psychol"},{"key":"pone.0290388.ref042","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1479-5868-9-102","article-title":"Towards parsimony in habit measurement: testing the convergent and predictive validity of an automaticity subscale of the Self-Report Habit Index","volume":"9","author":"B Gardner","year":"2012","journal-title":"Int J Behav Nutr Phys Act"},{"issue":"3","key":"pone.0290388.ref043","first-page":"A16","article-title":"Tracking Healthy Days\u2014a window on the health of older adults","volume":"2","author":"DG Moriarty","year":"2005","journal-title":"Preventing chronic disease"},{"issue":"10","key":"pone.0290388.ref044","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"RL Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"pone.0290388.ref045","doi-asserted-by":"crossref","unstructured":"Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. SLACK Incorporated Thorofare, NJ; 2002. p. 509\u201315.","DOI":"10.3928\/0048-5713-20020901-06"},{"issue":"9","key":"pone.0290388.ref046","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"K Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"issue":"6","key":"pone.0290388.ref047","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s11606-009-0981-1","article-title":"Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference","volume":"24","author":"EE Krebs","year":"2009","journal-title":"J Gen Intern Med"},{"issue":"1","key":"pone.0290388.ref048","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/mpr.197","article-title":"Structure analysis of Antonovsky\u2019s sense of coherence from an epidemiological mental health survey with a brief nine-item sense of coherence scale","volume":"16","author":"OM Klepp","year":"2007","journal-title":"Int J Methods Psychiatr Res"},{"issue":"4","key":"pone.0290388.ref049","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2307\/2136404","article-title":"A global measure of perceived stress","volume":"24","author":"S Cohen","year":"1983","journal-title":"J Health Soc Behav"},{"key":"pone.0290388.ref050","volume-title":"SAS for mixed models","author":"RC Littell","year":"1996"},{"key":"pone.0290388.ref051","volume-title":"Longitudinal data analysis","author":"D Hedeker","year":"2006"},{"issue":"21","key":"pone.0290388.ref052","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1002\/sim.2186","article-title":"A mixed\u2010effects regression model for three\u2010level ordinal response data","volume":"24","author":"R Raman","year":"2005","journal-title":"Statistics in Medicine"},{"issue":"6","key":"pone.0290388.ref053","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jclinepi.2014.12.006","article-title":"A review of the use of covariates in cluster randomized trials uncovers marked discrepancies between guidance and practice","volume":"68","author":"N Wright","year":"2015","journal-title":"Journal of clinical epidemiology"},{"key":"pone.0290388.ref054","volume-title":"Hierarchical Linear Models: Applications and Data Analysis Methods","author":"S Raudenbush","year":"2002","edition":"2"},{"key":"pone.0290388.ref055","volume-title":"Design and analysis of group-randomized trials: Monographs in Epidemiology and Biostatistics","author":"DM Murray","year":"1998"},{"issue":"5","key":"pone.0290388.ref056","doi-asserted-by":"crossref","first-page":"e1000065","DOI":"10.1371\/journal.pmed.1000065","article-title":"Preventing bias in cluster randomised trials","volume":"6","author":"B Giraudeau","year":"2009","journal-title":"PLoS medicine"},{"issue":"7418","key":"pone.0290388.ref057","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/bmj.327.7418.785","article-title":"Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals","volume":"327","author":"S Puffer","year":"2003","journal-title":"Bmj"},{"issue":"7441","key":"pone.0290388.ref058","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/bmj.328.7441.702","article-title":"CONSORT statement: extension to cluster randomised trials","volume":"328","author":"MK Campbell","year":"2004","journal-title":"Bmj"},{"issue":"1","key":"pone.0290388.ref059","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.2517-6161.1977.tb01600.x","article-title":"Maximum likelihood estimation from incomplete data","volume":"39","author":"AP Dempster","year":"1977","journal-title":"Journal of the Royal Statistical Society: Series B (Methodological)"},{"key":"pone.0290388.ref060","volume-title":"Statistical analysis with missing data","author":"RJA Little","year":"2014","edition":"2"},{"key":"pone.0290388.ref061","unstructured":"Fairclough DL. Design and analysis of quality of life studies in clinical trials: Chapman and Hall\/CRC; 2010."},{"key":"pone.0290388.ref062","volume-title":"Qualitative research & evaluation methods: Iintegrating theory and practice","author":"MQ Patton","year":"2015","edition":"4"},{"key":"pone.0290388.ref063","first-page":"145","volume-title":"Doing Qualitative Research","author":"RB Addison","year":"1999","edition":"2"},{"key":"pone.0290388.ref064","volume-title":"Qualitative data analysis: a methods sourcebook","author":"MB Miles","year":"2014","edition":"3"},{"issue":"2","key":"pone.0290388.ref065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"PA Harris","year":"2009","journal-title":"Journal of biomedical informatics"},{"key":"pone.0290388.ref066","doi-asserted-by":"crossref","first-page":"h2147","DOI":"10.1136\/bmj.h2147","article-title":"The PRECIS-2 tool: designing trials that are fit for purpose","volume":"350","author":"K Loudon","year":"2015","journal-title":"BMJ: British Medical Journal"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0321303","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0290388","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T20:05:56Z","timestamp":1730059556000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0290388"}},"subtitle":[],"editor":[{"given":"Sandra Ann","family":"Springer","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,9,8]]},"references-count":66,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0290388","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,8]]}}}